JP2020532531A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532531A5 JP2020532531A5 JP2020512411A JP2020512411A JP2020532531A5 JP 2020532531 A5 JP2020532531 A5 JP 2020532531A5 JP 2020512411 A JP2020512411 A JP 2020512411A JP 2020512411 A JP2020512411 A JP 2020512411A JP 2020532531 A5 JP2020532531 A5 JP 2020532531A5
- Authority
- JP
- Japan
- Prior art keywords
- nitric oxide
- ino
- oxide according
- administered
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 34
- 208000002815 pulmonary hypertension Diseases 0.000 claims 4
- 230000005021 gait Effects 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 238000002640 oxygen therapy Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762552022P | 2017-08-30 | 2017-08-30 | |
| US62/552,022 | 2017-08-30 | ||
| US201762611325P | 2017-12-28 | 2017-12-28 | |
| US62/611,325 | 2017-12-28 | ||
| PCT/US2018/048526 WO2019046415A1 (en) | 2017-08-30 | 2018-08-29 | USE OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY DISEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020532531A JP2020532531A (ja) | 2020-11-12 |
| JP2020532531A5 true JP2020532531A5 (enExample) | 2021-10-07 |
Family
ID=65526008
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512022A Pending JP2020532521A (ja) | 2017-08-30 | 2018-08-29 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2020512411A Pending JP2020532531A (ja) | 2017-08-30 | 2018-08-29 | 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用 |
| JP2023080033A Pending JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2024209997A Pending JP2025029093A (ja) | 2017-08-30 | 2024-12-03 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512022A Pending JP2020532521A (ja) | 2017-08-30 | 2018-08-29 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080033A Pending JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2024209997A Pending JP2025029093A (ja) | 2017-08-30 | 2024-12-03 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20200360647A1 (enExample) |
| EP (2) | EP3675840A4 (enExample) |
| JP (4) | JP2020532521A (enExample) |
| KR (1) | KR20200083443A (enExample) |
| CN (3) | CN111315283A (enExample) |
| AU (2) | AU2018323547A1 (enExample) |
| BR (1) | BR112020004205A2 (enExample) |
| CA (4) | CA3073948A1 (enExample) |
| IL (2) | IL272314A (enExample) |
| MX (2) | MX2020002194A (enExample) |
| PH (1) | PH12020500197A1 (enExample) |
| SG (1) | SG11202000893QA (enExample) |
| TW (3) | TW201919590A (enExample) |
| WO (2) | WO2019046415A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
| BR112019016708B1 (pt) | 2017-02-27 | 2024-01-30 | Third Pole, Inc | Sistemas de geração de óxido nítrico |
| EP4095094A1 (en) | 2017-02-27 | 2022-11-30 | Third Pole, Inc. | Systems and methods for ambulatory generation of nitric oxide |
| MX2021008418A (es) * | 2019-01-14 | 2021-08-19 | Bellerophon Therapeutics | Terapias de farmaco de combinacion de inhibidores de fosfodiesterasa tipo 5 (pde-5) y oxido nitrico inhalado. |
| WO2020232419A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
| CN114269685A (zh) | 2019-05-15 | 2022-04-01 | 第三极股份有限公司 | 用于一氧化氮生成的电极 |
| WO2021142472A1 (en) | 2020-01-11 | 2021-07-15 | Third Pole, Inc. | Systems and methods for nitric oxide generation with humidity control |
| US12239460B2 (en) * | 2020-05-06 | 2025-03-04 | Janssen Pharmaceuticals, Inc. | Controlling operation of drug administration devices using surgical hubs |
| WO2021243227A1 (en) * | 2020-05-29 | 2021-12-02 | Bellerophon Therapeutics | Method for pulsatile delivery of a gaseous drug |
| EP4167920A4 (en) | 2020-06-18 | 2024-06-12 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
| JP2024534608A (ja) | 2021-09-23 | 2024-09-20 | サード ポール，インコーポレイテッド | 一酸化窒素を送達するシステム及び方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2544724T3 (es) * | 2006-12-12 | 2015-09-03 | Gilead Sciences, Inc. | Composición para tratar una hipertensión pulmonar |
| WO2009048521A1 (en) * | 2007-10-11 | 2009-04-16 | Duke University | Potentiating the effect of compound comprising nitric oxide |
| WO2009099998A2 (en) * | 2008-01-31 | 2009-08-13 | Vanderbilt University | Therapeutic treatment for lung conditions |
| JP2011010865A (ja) * | 2009-06-30 | 2011-01-20 | Ikaria Holdings Inc | 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 |
| US20120093948A1 (en) * | 2009-11-20 | 2012-04-19 | Fine David H | Nitric Oxide Treatments |
| AU2011336358B2 (en) * | 2010-12-03 | 2016-09-29 | VERO Biotech LLC. | Nitric oxide treatments |
| MX363507B (es) * | 2012-05-31 | 2019-03-26 | Mallinckrodt Hospital Products Ip Ltd | Metodos para administrar óxido nítrico a la sangre arterial o arterializada. |
| KR102483889B1 (ko) * | 2012-12-04 | 2023-01-03 | 말린크로트 파마슈티칼스 아일랜드 리미티드 | 일산화질소 전달 동안 투약량의 희석을 최소화하기 위한 캐뉼라 |
| US9795756B2 (en) * | 2012-12-04 | 2017-10-24 | Mallinckrodt Hospital Products IP Limited | Cannula for minimizing dilution of dosing during nitric oxide delivery |
| CN106456666A (zh) * | 2014-01-10 | 2017-02-22 | Ino治疗有限责任公司 | 使用吸入性一氧化氮气体来治疗儿童的急性呼吸窘迫综合征的方法 |
| CN106572813B (zh) * | 2014-03-28 | 2020-07-17 | 沙普医疗系统公司 | 用于量化慢性疾病的多种可能形式对被报告呼吸困难的患者的贡献的可能性的模式识别系统 |
| BR112018011762A2 (pt) * | 2015-12-11 | 2018-12-04 | Vero Biotech LLC | método e aparelho para administração de gases inclu-indo óxido nítrico para combater fibrose |
| US20170182088A1 (en) * | 2015-12-28 | 2017-06-29 | Geno Llc | Method and apparatus for administering nitric oxide with supplemental drugs |
| US10398820B2 (en) * | 2016-02-12 | 2019-09-03 | Mallinckrodt Hospital Products IP Limited | Use and monitoring of inhaled nitric oxide with left ventricular assist devices |
-
2018
- 2018-08-29 SG SG11202000893QA patent/SG11202000893QA/en unknown
- 2018-08-29 EP EP18851496.2A patent/EP3675840A4/en not_active Withdrawn
- 2018-08-29 BR BR112020004205-6A patent/BR112020004205A2/pt unknown
- 2018-08-29 JP JP2020512022A patent/JP2020532521A/ja active Pending
- 2018-08-29 CN CN201880055684.1A patent/CN111315283A/zh active Pending
- 2018-08-29 CA CA3073948A patent/CA3073948A1/en active Pending
- 2018-08-29 JP JP2020512411A patent/JP2020532531A/ja active Pending
- 2018-08-29 US US16/643,167 patent/US20200360647A1/en not_active Abandoned
- 2018-08-29 KR KR1020207008998A patent/KR20200083443A/ko not_active Ceased
- 2018-08-29 CN CN202411395162.XA patent/CN120131593A/zh active Pending
- 2018-08-29 MX MX2020002194A patent/MX2020002194A/es unknown
- 2018-08-29 AU AU2018323547A patent/AU2018323547A1/en not_active Abandoned
- 2018-08-29 EP EP18852330.2A patent/EP3675719A4/en not_active Withdrawn
- 2018-08-29 AU AU2018324004A patent/AU2018324004A1/en not_active Abandoned
- 2018-08-29 WO PCT/US2018/048526 patent/WO2019046415A1/en not_active Ceased
- 2018-08-29 WO PCT/US2018/048524 patent/WO2019046413A1/en not_active Ceased
- 2018-08-29 US US16/643,198 patent/US20200188319A1/en not_active Abandoned
- 2018-08-29 CA CA3266320A patent/CA3266320A1/en active Pending
- 2018-08-29 CN CN201880055696.4A patent/CN111372577A/zh active Pending
- 2018-08-29 CA CA3073949A patent/CA3073949A1/en active Pending
- 2018-08-29 CA CA3266267A patent/CA3266267A1/en active Pending
- 2018-08-30 TW TW107130307A patent/TW201919590A/zh unknown
- 2018-08-30 TW TW107130330A patent/TWI887195B/zh active
- 2018-08-30 TW TW112149987A patent/TW202416939A/zh unknown
-
2020
- 2020-01-27 PH PH12020500197A patent/PH12020500197A1/en unknown
- 2020-01-28 IL IL272314A patent/IL272314A/en unknown
- 2020-01-28 IL IL272308A patent/IL272308A/en unknown
- 2020-02-26 MX MX2025004666A patent/MX2025004666A/es unknown
-
2023
- 2023-05-15 JP JP2023080033A patent/JP2023100985A/ja active Pending
-
2024
- 2024-12-03 JP JP2024209997A patent/JP2025029093A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020532531A5 (enExample) | ||
| JP2020033360A5 (enExample) | ||
| JP2020532521A5 (enExample) | ||
| EP4620525A3 (en) | Methods and compositions for treatment of pulmonary hypertension and other lung disorders | |
| RU2010132581A (ru) | Способы терапии заболеваний легких | |
| JP2016516016A5 (enExample) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2016520089A5 (enExample) | ||
| JP2015522603A5 (enExample) | ||
| JP2019507786A5 (enExample) | ||
| JP2018526459A5 (enExample) | ||
| JP2017508737A5 (enExample) | ||
| CN105412118B (zh) | 治疗急慢性呼吸困难的西药组合物及其制备方法 | |
| JP2016510040A5 (enExample) | ||
| MX2023002156A (es) | Acido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentan o-1-carboxilico y derivados del mismo para su uso en el tratamiento de enfermedades de las vias respiratorias. | |
| JPWO2020033768A5 (enExample) | ||
| JP2019504040A (ja) | 中等度〜重度のインフルエンザの処置 | |
| Bordier | Sleep apnoea in patients with heart failure: part II: therapy | |
| Bednarek | Overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea | |
| JP2017511307A5 (enExample) | ||
| JP2018502168A5 (enExample) | ||
| AR128201A1 (es) | USO DE ÓXIDO NÍTRICO INHALADO (iNO) PARA TRATAR PACIENTES CON HIPERTENSIÓN PULMONAR ASOCIADA CON SARCOIDOSIS (PH-SARC) | |
| JP2017524732A5 (enExample) | ||
| Pradhan et al. | Efficacy of dexmedetomidine in attenuating hemodynamic and airway responses during extubation: a randomized double-blind study | |
| AR119669A1 (es) | USO DE ÓXIDO NÍTRICO INHALADO (iNO) PARA MEJORAR LOS NIVELES DE ACTIVIDAD EN PACIENTES CON AFECCIONES PULMONARES |